McCluskey, Elizabeth S.
Liu, Nathan
Pandey, Abhimaneu
Marchetti, Nathaniel
Kelsen, Steven G.
Sajjan, Umadevi S.
Funding for this research was provided by:
National Center for Complementary and Integrative Health (AT009991)
National Heart, Lung, and Blood Institute (HL157258)
Article History
Received: 19 July 2023
Accepted: 20 February 2024
First Online: 11 March 2024
Declarations
:
: EM, AP, NL, NM SK and US declare no competing interests.
: The clinical trial with quercetin in COPD patients was approved by Temple University IRB # #25738.
: Subjects enrolled in clinical trial provided return consent to participate in the study.
: The patients in the clinical trial provided written consent to use their samples in the ancillary studies and publish the results.